Lee YE - Search Results

1

Rationally designed redirection of natural killer cells anchoring a cytotoxic ligand for pancreatic cancer treatment.

Lee YE, Ju A, Choi HW, Kim JC, Kim EE, Kim TS, Kang HJ, Kim SY, Jang JY, Ku JL, Kim SC, Jun E, Jang M. Lee YE, et al. J Control Release. 2020 Oct 10;326:310-323. doi: 10.1016/j.jconrel.2020.07.016. Epub 2020 Jul 16. J Control Release. 2020. PMID: 32682905

2

A carrier-free multiplexed gene editing system applicable for suspension cells.

Ju A, Lee SW, Lee YE, Han KC, Kim JC, Shin SC, Park HJ, EunKyeong Kim E, Hong S, Jang M. Ju A, et al. Among authors: lee sw, lee ye. Biomaterials. 2019 Oct;217:119298. doi: 10.1016/j.biomaterials.2019.119298. Epub 2019 Jun 25. Biomaterials. 2019. PMID: 31280073 Free article.

3

Corrigendum to "A carrier-free multiplexed gene editing system applicable for suspension cells" [Biomaterials 217 (2019) 119298].

Ju A, Lee S, Lee YE, Han KC, Kim JC, Shin SC, Park HJ, EunKyeong Kim E, Hong S, Jang M. Ju A, et al. Among authors: lee ye, lee s. Biomaterials. 2019 Dec;223:119487. doi: 10.1016/j.biomaterials.2019.119487. Epub 2019 Sep 14. Biomaterials. 2019. PMID: 31526951 No abstract available.

4

Streamlined selection of cancer antigens for vaccine development through integrative multi-omics and high-content cell imaging.

Han KC, Park D, Ju S, Lee YE, Heo SH, Kim YA, Lee JE, Lee Y, Park KH, Park SH, Lee HJ, Lee C, Jang M. Han KC, et al. Among authors: lee y, lee je, lee ye, lee c, lee hj. Sci Rep. 2020 Apr 3;10(1):5885. doi: 10.1038/s41598-020-62244-z. Sci Rep. 2020. PMID: 32245999 Free PMC article.

5

A novel therapeutic modality using CRISPR-engineered dendritic cells to treat allergies.

Kim B, Lee YE, Yeon JW, Go GY, Byun J, Lee K, Lee HK, Hur JK, Jang M, Kim TH. Kim B, et al. Among authors: lee k, lee ye, lee hk. Biomaterials. 2021 Jun;273:120798. doi: 10.1016/j.biomaterials.2021.120798. Epub 2021 Apr 10. Biomaterials. 2021. PMID: 33895493

6

Facile discovery of a therapeutic agent for NK-mediated synergistic antitumor effects using a patient-derived 3D platform.

Lee YE, Yuk CM, Lee M, Han KC, Jun E, Kim TS, Ku JL, Im SG, Lee E, Jang M. Lee YE, et al. Among authors: lee e, lee m. Biomater Sci. 2022 Feb 1;10(3):678-691. doi: 10.1039/d1bm01699g. Biomater Sci. 2022. PMID: 34940764

7

Cytomorphological Features of Hyperchromatic Crowded Groups in Liquid-Based Cervicovaginal Cytology: A Single Institutional Experience.

Lee Y, Lee C, Park IA, An HJ, Kim H. Lee Y, et al. J Pathol Transl Med. 2019 Nov;53(6):393-398. doi: 10.4132/jptm.2019.08.14. Epub 2019 Sep 16. J Pathol Transl Med. 2019. PMID: 31525835 Free PMC article.

8

The First Korean Case of Griscelli Syndrome Type 2 With Hemophagocytic Lymphohistiocytosis and Partial Albinism.

Lee Y, Park HJ, Kang HJ, Ko JM, Kim B, Chang YH, Kim HK, Lee JS, Kim MJ, Park SS, Seong MW. Lee Y, et al. Ann Lab Med. 2022 May 1;42(3):384-388. doi: 10.3343/alm.2022.42.3.384. Ann Lab Med. 2022. PMID: 34907113 Free PMC article. No abstract available.

9

Therapeutic Effects against Tissue Necrosis of Remote Ischemic Preconditioning Combined with Human Adipose-Derived Stem Cells in Random-Pattern Skin Flap Rat Models.

Pak CS, Moon SY, Lee YE, Kang HJ. Pak CS, et al. Among authors: lee ye. J Invest Surg. 2021 Dec;34(12):1304-1311. doi: 10.1080/08941939.2020.1795750. Epub 2020 Jul 20. J Invest Surg. 2021. PMID: 32691637 Free article.

10

Genetic profile of primary plasma cell leukemia in Korea: comparison with plasma cell myeloma.

Lee Y, Yun J, Jeong D, Ryu S, Kwon SR, Yun H, Kim SM, Park JH, Lee DS. Lee Y, et al. Leuk Lymphoma. 2022 Feb;63(2):385-394. doi: 10.1080/10428194.2021.1983568. Epub 2021 Oct 1. Leuk Lymphoma. 2022. PMID: 34592901

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

635 results

Search Page

Filters